Leilei Wu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Evolutionary Trajectory of Radioresistance in Lung Cancer Brain Metastasis Organoids.

Evolutionary Trajectory of Radioresistance in Lung Cancer Brain Metastasis Organoids.

Journal: Biological procedures online
Published: March 14, 2026

Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.

Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.

Journal: The New England journal of medicine
Published: February 25, 2026

Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.

Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.

Journal: Frontiers in immunology
Published: January 07, 2026

Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response.

Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response.

Journal: Experimental hematology & oncology
Published: November 20, 2025

c-MET expression and immune landscape in locally advanced patients with non-small cell lung cancer undergoing radiochemotherapy and consolidative immunotherapy.

c-MET expression and immune landscape in locally advanced patients with non-small cell lung cancer undergoing radiochemotherapy and consolidative immunotherapy.

Journal: Translational lung cancer research
Published: September 08, 2025

ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2.

ROCK1 inhibition primes anti-tumor immunity in EGFR-mutant NSCLC by triggering PD-L1 degradation mediated by SMURF2.

Journal: Molecular cancer
Published: July 14, 2025

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance.

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance.

Journal: Cancer medicine
Published: June 27, 2025

DCAF12 Ubiquitin Ligase Promotes Lung Cancer Metastasis by Modulating the TRiC/CCT Chaperonin Complex.

DCAF12 Ubiquitin Ligase Promotes Lung Cancer Metastasis by Modulating the TRiC/CCT Chaperonin Complex.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 04, 2025

RSK1 reprograms the ubiquitin pathway to promote immune suppression.

RSK1 reprograms the ubiquitin pathway to promote immune suppression.

Journal: Cell reports
Published: January 16, 2025

Integration of Circulating Tumor DNA and Metabolic Parameters on 18F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Integration of Circulating Tumor DNA and Metabolic Parameters on 18F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2024

Efficient Predictor for Immunotherapy Efficacy: Detecting Pan-Clones Effector Tumor Antigen-Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens.

Efficient Predictor for Immunotherapy Efficacy: Detecting Pan-Clones Effector Tumor Antigen-Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 19, 2024

Environmental Health and Safety Implications of the Interplay Between Microplastics and the Residing Biofilm.

Environmental Health and Safety Implications of the Interplay Between Microplastics and the Residing Biofilm.

Journal: Environment & health (Washington, D.C.)
Published: July 31, 2024
Showing 1-12 of 48

Last Updated: 09/26/2026